

Immunology for the Rheumatologist: Type I Interferon & Skin Disease
Dec 10, 2024
Dr. Victoria Werth, Chief of Dermatology at the VA Medical Center and Professor at the University of Pennsylvania, sheds light on the role of Type I interferons in autoimmune skin diseases like cutaneous lupus and dermatomyositis. She discusses the inflammation mechanisms and skin manifestations linked to these conditions, highlighting the challenges of misdiagnosis. Dr. Werth also explores advancements in immunotherapy, the personalized use of hydroxychloroquine, and the importance of collaboration in improving lupus treatment outcomes.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Intro
00:00 • 4min
Interferon-Induced Skin Manifestations
04:05 • 6min
Impact of Immunotherapy on Autoimmune Skin Diseases
10:33 • 17min
The Role of Hydroxychloroquine in Managing Photosensitive Conditions
27:12 • 2min
Advancements in Connective Tissue Disease Treatments
29:13 • 6min
Therapeutics in Immune Dermatology: Focus on IVIG for Myositis
35:31 • 4min
Enhancing Lupus Treatment Through Collaboration
39:06 • 9min